← Eichor
Study identifier: NCT06999005 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Longitudinal Evaluation of Minimally Invasive Protocols for Dental Caries in Brazilian Schoolchildren

Condition: Dental Caries  ·  Sponsor: University of Nove de Julho

PhaseNA
Planned participants2500
Who can joinAll sexes, 6 Years to 12 Years
Healthy volunteersYes

About this study

This multicenter longitudinal interventional study aims to evaluate minimally invasive protocols for the prevention and control of dental caries in Brazilian schoolchildren under routine public health conditions. In the first phase, 50,000 children aged 6 to 12 years from public schools in five Brazilian cities will undergo dental screening using ICDAS criteria and receive preventive and educational oral health measures. In the longitudinal treatment phase, 2,500 children diagnosed with active carious lesions will be managed according to ICDAS-based minimally invasive treatment protocols. Participants will be followed every three months for up to 24 months.

This description comes directly from the study's public registry record.

Talk to the study team

Sandra K Bussadori  ·  +55 11 3385-9241  ·  sandra.skb@gmail.com

Elaine M Santos  ·  +55 13 3228-3400

Always discuss trial participation with your own doctor first.

Locations (1)

Universidade Metropolitana de Santos - UNIMESSantos, São Paulo, BrazilRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06999005